4.3 Article

Mesoporous Polydopamine Nanobowls Toward Combined Chemo- and Photothermal Cancer Therapy

Journal

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/ppsc.202200015

Keywords

efficient drug nanocarrier; mesoporous nanobowls; photothermal treatments; polydopamine

Funding

  1. Monash Centre for Electron Microscopy (MCEM), Monash Micro Imaging, the Flow Cytometry Facility, Monash University
  2. Monash Graduate Scholarship (MGS)
  3. Monash International Tuition Scholarship (MITS)
  4. Faculty of Science Dean's International Postgraduate Research Scholarship, Monash University
  5. Graduate Research Completion Award (GRCA), Monash University

Ask authors/readers for more resources

This study explores a new approach for targeted cancer treatment by combining chemo- and photothermal therapy using bio-derived polydopamine (PDA) mesoporous nanobowls, which possess exceptional biocompatibility. The results demonstrate that loading the anticancer drug doxorubicin (DOX) into the nanobowls and treating with near-infrared (NIR) illumination significantly enhances pharmaceutical cytotoxicity to cancer cells compared to free DOX. Additionally, combining the DOX loaded nanobowls with photothermal treatment results in nearly 100% cell death. This research highlights the potential of PDA mesoporous nanobowls as a scaffold for combined chemo- and photothermal therapy, offering new opportunities for treating advanced cancer.
To enhance therapeutic efficacy and reduce side effects in cancer treatment, multimodal therapies are increasingly desired. In particular, combined chemo- and photothermal therapy has been developed as an approach with significantly higher therapeutic efficacy. However, long-term cytotoxicity arising particularly from poor biodegradability of the nanoparticles typically used for such treatment remains a challenge. In the present in vitro study, a new approach targeted toward cancer treatment that combines chemo- and photothermal therapy using bio-derived polydopamine (PDA) bowl-shaped mesoporous nanoparticles with exceptional biocompatibility is indicated. The potential of PDA mesoporous nanobowls as a new chemo- and photothermal agent was explored by loading the anti-cancer drug doxorubicin (DOX) into nanobowls and investigating their photothermal performance upon near-infrared (NIR) illumination. Strikingly, DOX loaded nanobowls show significantly higher pharmaceutical cytotoxicity to HeLa cells in vitro in comparison with free DOX due to their preferential uptake into cells. Following this with photothermal treatment resulted in nearly 100% cell death from the combined treatment of DOX loaded nanobowls and NIR illumination. This first step highlights the potential of PDA mesoporous nanobowls as a scaffold for combined chemo- and photothermal therapy for cancer treatment that offers new opportunities for combined physicochemical therapies to treat advanced disease states.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available